OliX Pharmaceuticals To Participate In BIO Partnering At JPM And Biotech Showcase 2022 Conferences

Published by
The Street

By GlobeNewswire SUWON, Republic of Korea., Jan. 03, 2022 (GLOBE NEWSWIRE) — OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company’s management will hold one-on-one meetings at BIO Partnering at JPM from January 10-14, 2022. The Company’s management will also participate in Biotech Showcase 2022, being held virtually from January 10-12, 2022 and January 17-19, 2022. Dong Ki Lee, Ph.D., Founder and Chief Executive Officer, Sun Woo Hong, Ph.D., Head of Research and Development, and June Park, Principal Scientist, will be availabl…

Read More

You may also like...

Leave a Reply